Erchonia Lunula Laser

Erchonia Lunula Laser is a non‑thermal, low‑level laser therapy (LLLT) device designed to improve the appearance of nails affected by onychomycosis. It emits two calibrated wavelengths that work without heat and without downtime, supporting gradual improvement as new nail grows lunula nail fungus.

Value Erchonia Lunula Laser for Clinics

• Offers a non‑pharmacological option for patients who avoid systemic medications
• Introduces a modern service that differentiates your practice from competitors
• Can be packaged into multi‑session plans with clear ROI potential

Device Features Erchonia Lunula Laser

Synergistic Dual‑Wavelength

Combines two wavelengths to help create a healthier nail environment.

Fast, Comfortable Sessions

Approximately 12 minutes per foot, no anesthesia, and no heat sensation.

Ergonomic Design Lanula Laser

Stable foot platform, precise laser placement, and an easy‑to‑use interface.

Non‑Invasive & Non‑Ablative

No tissue damage, minimizing risk and maximizing patient comfort.

Technical Specifications

• Delivery System: Patented Line Generated Laser Diode System (Rotating beam for wide-area coverage).

• Wavelength Configuration: Dual-wavelength combination of 635nm (Red) & 405nm (Violet).

• Safety Category: Class 2 Laser (IEC 60825-1). Safe for the eyes without heavy protective eyewear; non-thermal.

• Output Energy: Calibrated to < 20mW per diode for maximum tissue safety (Cold Laser).

• Operation Mode: Continuous Wave with specific modulation for deep tissue penetration.

• Interface: Full Color Touch Screen with intuitive navigation.

• Unit Dimensions: Ergonomic table-top design, approx. 10″ (H) x 10″ (W) x 11″ (L).

• Weight: Approx. 6 lbs (2.7 kg) – Portable and easy to relocate.

• Power Requirements: Universal 100-240 VAC, 50/60 Hz.

• Certification: FDA 510(k) Market Cleared for the temporary increase of clear nail in patients with onychomycosis.

How It Works

Non‑Thermal Photobiomodulation

Light energy triggers cellular responses that support nail and periungual tissue conditions without heating or damaging tissue.

Gradual Improvement

Results appear as a clearer nail plate grows out from the matrix over time.

Safety & Compliance

• FDA 510(k) clearance for the temporary increase of clear nail in patients with onychomycosis
• Comfortable, safe procedure with no post‑treatment downtime

Outcome Guidance & Supportive Care

• Consistent session scheduling strongly influences results
• Maintain foot hygiene, manage shoe/sock moisture, and trim nails properly
• Individual outcomes vary based on baseline condition and personal factors

Purchasing & Support Options

• Available as new units with distributor‑specific warranties
• After‑sales support for device maintenance and calibration